Financial Enhancement Group’s Bio-Techne TECH Stock Holding History

Financial Enhancement Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$14K	–	298
2022 Q3	$14K	Hold	200	–	–	﹤0.01%	177
2022 Q2	$17K	Hold	200	–	–	﹤0.01%	171
2022 Q1	$22K	Hold	200	–	–	﹤0.01%	164
2021 Q4	$26K	Hold	200	–	–	﹤0.01%	165
2021 Q3	$24K	Hold	200	–	–	﹤0.01%	165
2021 Q2	$23K	Hold	200	–	–	﹤0.01%	153
2021 Q1	$19K	Hold	200	–	–	﹤0.01%	155
2020 Q4	$16K	Hold	200	–	–	﹤0.01%	186
2020 Q3	$12K	Hold	200	–	–	﹤0.01%	169
2020 Q2	$13K	Hold	200	–	–	﹤0.01%	174
2020 Q1	$9K	Hold	200	–	–	﹤0.01%	201
2019 Q4	$11K	Hold	200	–	–	﹤0.01%	194
2019 Q3	$10K	Hold	200	–	–	﹤0.01%	200
2019 Q2	$10K	Hold	200	–	–	﹤0.01%	197
2019 Q1	$10K	Buy	+200	New	+$9K	﹤0.01%	218

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Financial Enhancement Group's TECH Position: Q4 2022 in Review

Financial Enhancement Group sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 200 shares — an estimated $14K sold.

Financial Enhancement Group first reported a position in TECH in Q1 2019 and held it in 15 quarters. The position peaked at $26K in Q4 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Financial Enhancement Group reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Financial Enhancement Group sold 200 Bio-Techne shares in Q4 2022, an estimated $14K.
Financial Enhancement Group first reported a position in Bio-Techne in Q1 2019 and held it in 15 quarters.
Financial Enhancement Group's Bio-Techne position peaked at $26K in Q4 2021.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.